These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 30059685
1. Evaluation of Cancer Specific Mortality with Surgery versus Radiation as Primary Therapy for Localized High Grade Prostate Cancer in Men Younger Than 60 Years. Huang H, Muscatelli S, Naslund M, Badiyan SN, Kaiser A, Siddiqui MM. J Urol; 2019 Jan; 201(1):120-128. PubMed ID: 30059685 [Abstract] [Full Text] [Related]
2. Combined External Beam Radiation Therapy and Brachytherapy versus Radical Prostatectomy with Adjuvant Radiation Therapy for Gleason 9-10 Prostate Cancer. Muralidhar V, Mahal BA, Butler S, Lamba N, Yang DD, Leeman J, D'Amico AV, Nguyen PL, Trinh QD, Orio PF, King MT. J Urol; 2019 Nov; 202(5):973-978. PubMed ID: 31144590 [Abstract] [Full Text] [Related]
3. Morbidity and Mortality of Locally Advanced Prostate Cancer: A Population Based Analysis Comparing Radical Prostatectomy versus External Beam Radiation. Feldman AS, Meyer CP, Sanchez A, Krasnova A, Reznor G, Menon M, Kibel AS, Choueiri TK, Lipsitz SR, Sun M, Trinh QD. J Urol; 2017 Nov; 198(5):1061-1068. PubMed ID: 28552709 [Abstract] [Full Text] [Related]
4. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis. Satkunasivam R, Kim AE, Desai M, Nguyen MM, Quinn DI, Ballas L, Lewinger JP, Stern MC, Hamilton AS, Aron M, Gill IS. J Urol; 2015 Aug; 194(2):378-85. PubMed ID: 25711194 [Abstract] [Full Text] [Related]
6. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study. Culp SH, Schellhammer PF, Williams MB. Eur Urol; 2014 Jun; 65(6):1058-66. PubMed ID: 24290503 [Abstract] [Full Text] [Related]
17. Comparative effectiveness of surgery versus external beam radiation with/without brachytherapy in high-risk localized prostate cancer. Yin M, Zhao J, Monk P, Martin D, Folefac E, Joshi M, Jin N, Mortazavi A, Verschraegen C, Clinton S. Cancer Med; 2020 Jan 06; 9(1):27-34. PubMed ID: 31697452 [Abstract] [Full Text] [Related]
18. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL. Ann Intern Med; 2008 Mar 18; 148(6):435-48. PubMed ID: 18252677 [Abstract] [Full Text] [Related]
19. Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. Kibel AS, Ciezki JP, Klein EA, Reddy CA, Lubahn JD, Haslag-Minoff J, Deasy JO, Michalski JM, Kallogjeri D, Piccirillo JF, Rabah DM, Yu C, Kattan MW, Stephenson AJ. J Urol; 2012 Apr 18; 187(4):1259-65. PubMed ID: 22335870 [Abstract] [Full Text] [Related]
20. Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis. Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU. Eur Urol; 2020 Jan 18; 77(1):3-10. PubMed ID: 30992160 [Abstract] [Full Text] [Related] Page: [Next] [New Search]